| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1151.4 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1151.4/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.4 |
| Version | 20160713 |
| Status | active |
| Date | 2016-07-13T01:00:02-04:00 |
| Name | BCGBacillusCalmetteGuerinTice |
| Title | BCG Bacillus Calmette Guerin, Tice |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: BCG is used for the treatment of non muscle invasive bladder cancer and is administered intravesically),(Data Element Scope: The intent of this data element is to include BCG as a treatment for non muscle invasive bladder cancer),(Inclusion Criteria: Bacillus Calmette Guerin for intravesical use),(Exclusion Criteria: None) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
| rxnorm | RxNorm |
No narrative content found in resource
FHIR